Literature DB >> 22479109

Use of parenteral fish oil to reverse cholestasis induced by parenteral nutrition in infants with intestinal failure: single-centre case series.

Denise Reniers1, Irina Rajakumar, Suzanne Ratko, Paul Atkison.   

Abstract

Entities:  

Year:  2012        PMID： 22479109      PMCID： PMC3282195          DOI： 10.4212/cjhp.v65i1.1100

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  10 in total

1.  Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease.

Authors:  R D Christensen; E Henry; S E Wiedmeier; J Burnett; D K Lambert
Journal:  J Perinatol       Date:  2007-03-08       Impact factor: 2.521

Review 2.  Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

Authors:  Vincent E de Meijer; Kathleen M Gura; Hau D Le; Jonathan A Meisel; Mark Puder
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-07-01       Impact factor: 4.016

3.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children.

Authors:  V Colomb; A Jobert-Giraud; F Lacaille; O Goulet; J C Fournet; C Ricour
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 Nov-Dec       Impact factor: 4.016

Review 5.  Parenteral nutrition-associated liver complications in children.

Authors:  Imad F Btaiche; Nabil Khalidi
Journal:  Pharmacotherapy       Date:  2002-02       Impact factor: 4.705

6.  Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.

Authors:  Michael D Rollins; Eric R Scaife; W Daniel Jackson; Rebecka L Meyers; Cecilia W Mulroy; Linda S Book
Journal:  Nutr Clin Pract       Date:  2010-04       Impact factor: 3.080

7.  Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program.

Authors:  Paul R Atkison; B Catherine Ross; Sandy Williams; John Howard; John Sommerauer; Douglas Quan; William Wall
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

Review 8.  New approaches to parenteral nutrition in infants and children.

Authors:  R G Heine; J E Bines
Journal:  J Paediatr Child Health       Date:  2002-10       Impact factor: 1.954

9.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

Authors:  George Ekema; Diego Falchetti; Giovanni Boroni; Anna Rita Tanca; Cristian Altana; Laura Righetti; Michela Ridella; Marco Gambarotti; Luisa Berchich
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545
  10 in total
  1 in total

1.  Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.

Authors:  Prathima Nandivada; Meredith A Baker; Paul D Mitchell; Alison A O'Loughlin; Alexis K Potemkin; Lorenzo Anez-Bustillos; Sarah J Carlson; Duy T Dao; Gillian L Fell; Kathleen M Gura; Mark Puder
Journal:  Am J Clin Nutr       Date:  2016-08-10       Impact factor: 7.045
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.